UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk

British journal of cancer, 2013-06, Vol.108 (11), p.2372-2380

2013

Volltextzugriff (PDF)

Novel approaches with targeted therapies in bladder cancer: Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

Critical reviews in oncology/hematology, 2003-06, Vol.46, p.85-104

2003

Volltextzugriff (PDF)

Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice

Clinical cancer research, 1999-02, Vol.5 (2), p.257-265

1999

Volltextzugriff (PDF)

Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes

American journal of human genetics, 2006-03, Vol.78 (3), p.464-479

2006

Volltextzugriff (PDF)

Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l study

Cancer gene therapy, 2014-03, Vol.21 (3), p.91-94

2014

Volltextzugriff (PDF)

Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VAC

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4005-4013

2001

Volltextzugriff (PDF)

Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule

Clinical cancer research, 1999-10, Vol.5 (10), p.2726-2734

1999

Volltextzugriff (PDF)

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Clinical cancer research, 2000-12, Vol.6 (12), p.4874-4884

2000

Volltextzugriff (PDF)

Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation

Cancer gene therapy, 2011-09, Vol.18 (9), p.609-616

2011

Volltextzugriff (PDF)

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2290-2299

2000

Volltextzugriff (PDF)

STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA

The Journal of urology, 1998-04, Vol.159 (4), p.1163-1167

1998

Volltextzugriff (PDF)

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (4), p.808-814

1998

Volltextzugriff (PDF)

Controversies in Ilioinguinal Lymphadenectomy

Urologic clinics of North America, 2010-08, Vol.37 (3), p.421-434

2010

Volltextzugriff (PDF)

p53 and RB expression predict progression in T1 bladder cancer

Clinical cancer research, 1998-04, Vol.4 (4), p.829-834

1998

Volltextzugriff (PDF)

Efficacy of a single intravesical treatment with Ad-IFN Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation

Cancer gene therapy, 2006-02, Vol.13 (2), p.125-130

2006

Volltextzugriff (PDF)

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

Clinical cancer research, 2000-07, Vol.6 (7), p.2635-2643

2000

Volltextzugriff (PDF)

A STAGE SPECIFIC APPROACH TO TUMOR SURVEILLANCE AFTER RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER

The Journal of urology, 1999-09, Vol.162 (3), p.710-714

1999

Volltextzugriff (PDF)

EVALUATION OF NMP22 IN THE DETECTION OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER

The Journal of urology, 1998-02, Vol.159 (2), p.394-398

1998

Volltextzugriff (PDF)

The role of angiogenesis in prostate and other urologic cancers: a review

Canadian Medical Association journal, 2001-03, Vol.164 (5), p.662

2001

Volltextzugriff (PDF)

UP-3.017: Cytoplasmic MislocalizatIon of the Orphan Nuclear Receptor is a Prognostic Factor in Bladder Cancer

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S299-S300

2009

Volltextzugriff (PDF)

E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer

Clinical genetics, 2006-09, Vol.70 (3), p.240-245

2006

Volltextzugriff (PDF)

Highly Metastatic Human Prostate Cancer Growing within the Prostate of Athymic Mice Overexpresses Vascular Endothelial Growth Factor

Clinical cancer research, 1999-04, Vol.5 (4), p.783-789

1999

Volltextzugriff (PDF)

Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (4), p.872-879

1999

Volltextzugriff (PDF)

Metastatic model for human prostate cancer using orthotopic implantation in nude mice

JNCI : Journal of the National Cancer Institute, 1992-06, Vol.84 (12), p.951-957

1992

Volltextzugriff (PDF)

1 – 25 von 348

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Englisch
(348)

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(197)
Humans
(185)
Male
(125)
Biological And Medical Sciences
(112)
Medical Sciences
(111)
Urology & Nephrology
(101)
Female
(100)
Urinary Bladder Neoplasms - Pathology
(92)
Middle Aged
(88)
Aged
(86)
Oncology
(84)
Bladder Cancer
(78)
Nephrology. Urinary Tract Diseases
(72)
Tumors Of The Urinary System
(69)
Urology
(60)
Urinary Tract. Prostate Gland
(57)
Urinary Bladder Neoplasms - Surgery
(48)
Retrospective Studies
(46)
Urinary Bladder Neoplasms - Drug Therapy
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk

Novel approaches with targeted therapies in bladder cancer: Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice

Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes

Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNα/Syn3 treatment in a phase l study

Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VAC

Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation

Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

STAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration

Controversies in Ilioinguinal Lymphadenectomy

p53 and RB expression predict progression in T1 bladder cancer

Efficacy of a single intravesical treatment with Ad-IFN Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

A STAGE SPECIFIC APPROACH TO TUMOR SURVEILLANCE AFTER RADICAL CYSTECTOMY FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDER

EVALUATION OF NMP22 IN THE DETECTION OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER

The role of angiogenesis in prostate and other urologic cancers: a review

UP-3.017: Cytoplasmic MislocalizatIon of the Orphan Nuclear Receptor is a Prognostic Factor in Bladder Cancer

E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer

Highly Metastatic Human Prostate Cancer Growing within the Prostate of Athymic Mice Overexpresses Vascular Endothelial Growth Factor

Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β

Metastatic model for human prostate cancer using orthotopic implantation in nude mice

Suchergebnisse filtern